Skip to main content

Animations

MJFF Publications

4551 - 4575 of 9140 Results
Title
Year
  • Year
  • 2019
  • 2016
  • 2024
  • 2012
  • 2020
  • 2014
  • 2014
  • 2018
  • 2013
  • 2019
  • 2020
  • 2019
  • 2017
  • 2020
  • 2019
  • 2020
  • 2018
  • 2019
  • 2019
  • 2017
  • 2017
  • 2023
  • 2020
  • 2019
  • 2020
  • Summary Details
    OPEN
    Title: The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease
    Journal Name: Cell Death & Differentiation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41418-019-0408-4
    Citation Count: 131
  • Summary Details
    OPEN
    Title: A multivariate nonlinear mixed effects model for longitudinal image analysis: Application to amyloid imaging
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2016.04.001
    Citation Count: 89
  • Summary Details
    OPEN
    Title: Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adq3539
    Citation Count: 32
  • P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteers
    2012
    Summary Details
    RESTRICTED
    Title: P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteers
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2012.05.296
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Reply to Comment on: The Most Bothersome Aspects of off Periods Reported by Individuals with Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13021
    Citation Count: 0
  • Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)
    2014
    Summary Details
    RESTRICTED
    Title: Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.82.10_supplement.p1.016
    Citation Count: 0
  • Fox Trial Finder, un nouvel outil pour la recherche clinique
    2014
    Summary Details
    RESTRICTED
    Title: Fox Trial Finder, un nouvel outil pour la recherche clinique
    Journal Name: Revue Neurologique
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurol.2014.01.360
    Citation Count: 0
  • O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACH
    2018
    Summary Details
    RESTRICTED
    Title: O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACH
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2018.06.2691
    Citation Count: 0
  • No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)
    2013
    Summary Details
    RESTRICTED
    Title: No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p04.187
    Citation Count: 0
  • Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)
    2019
    Summary Details
    RESTRICTED
    Title: Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-011
    Citation Count: 0
  • Summary Details
    OPEN
    Title: 4319 Team Science in Parkinson’s Research: Connecting Clinicians and Computational Teams
    Journal Name: Journal of Clinical and Translational Science
    Publisher: Cambridge University Press (CUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1017/cts.2020.359
    Citation Count: 0
  • Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)
    2019
    Summary Details
    RESTRICTED
    Title: Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-001
    Citation Count: 0
  • Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)
    2017
    Summary Details
    RESTRICTED
    Title: Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p4.007
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Creating a patient‐centered guide to navigating cognitive change in Parkinson’s disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.041115
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Abstract #81: Improving Neurostimulation Clinical Trial Design with Patient Experience Data
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brs.2018.12.088
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Screening peripheral biopsies for alpha‐synuclein pathology using deep machine learning
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.047358
    Citation Count: 0
  • A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)
    2018
    Summary Details
    RESTRICTED
    Title: A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p5.068
    Citation Count: 0
  • Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)
    2019
    Summary Details
    RESTRICTED
    Title: Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-008
    Citation Count: 0
  • Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)
    2019
    Summary Details
    RESTRICTED
    Title: Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p5.8-050
    Citation Count: 0
  • Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear (S1.002)
    2017
    Summary Details
    RESTRICTED
    Title: Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear (S1.002)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.s1.002
    Citation Count: 0
  • Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)
    2017
    Summary Details
    RESTRICTED
    Title: Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p1.013
    Citation Count: 0
  • Summary Details
    OPEN
    Title: 6 Association Between American Football Play and Parkinson's Disease: Analysis of the Fox Insight Data Set
    Journal Name: Journal of the International Neuropsychological Society
    Publisher: Cambridge University Press (CUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1017/s1355617723005507
    Citation Count: 0
  • Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design (4402)
    2020
    Summary Details
    RESTRICTED
    Title: Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design (4402)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4402
    Citation Count: 0
  • Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants (P3.8-006)
    2019
    Summary Details
    RESTRICTED
    Title: Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants (P3.8-006)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-006
    Citation Count: 0
  • Carepartner Communication on Parkinson Disease Psychosis (4116)
    2020
    Summary Details
    RESTRICTED
    Title: Carepartner Communication on Parkinson Disease Psychosis (4116)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4116
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.